Concepedia

Michael Jarman

MJ

Statistics

Publications

152

Citations

8.3K

H-Index

50

Active since

1959

Affiliations

Institute of Cancer Research(Current)

Royal Marsden NHS Foundation Trust

Royal Marsden Hospital

Michael Jarman is an author at Institute of Cancer Research specializing in pharmacology, medicine, and medicinal chemistry.

ORCID

Publications per year

1959–2023

152

Publications

152

Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

Anne O’Donnell, Ian Judson, Mitch Dowsett et al. · British Journal of Cancer · 2004 · 384 citations · Full text

, , +17

Novel Steroidal Inhibitors of Human Cytochrome P45017.alpha.-Hydroxylase-C17,20-lyase): Potential Agents for the Treatment of Prostatic Cancer

Gerard A. Potter, S. Elaine Barrie, Michael Jarman et al. · Journal of Medicinal Chemistry · 1995 · 380 citations · Full text

, , +13

Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide

T.A. Connors, Peter J. Cox, Peter B. Farmer et al. · Biochemical Pharmacology · 1974 · 344 citations

, , +12

Pharmacology of novel steroidal inhibitors of cytochrome P45017 (17α-hydroxylase/C17–20 lyase)

S. Elaine Barrie, Gerard A. Potter, Phyllis M. Goddard et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1994 · 255 citations

, , +16

Synthetic Procedures in Nucleic Acid Chemistry

Michael Jarman · Carbohydrate Research · 1969 · 252 citations

, , +14

1–5 of 152